$7.0M
The seed round was led by The Discovery Lab of IBA to support product validation and laboratory expansion.
SB
Signatur Biosciences
Signatur Biosciences develops decentralised molecular diagnostic tests for local hospital use.
London, UK—Founded 2022
$7.0MTotal raised
Precision diagnostics startup developing decentralised molecular tests for cancer care.
Categories
Founders
Cd
Celestin de Wergifosse
CEO